Cannabis use during pregnancy is associated with a host of negative outcomes.
Here’s how the Academy of Organizational and Occupational Psychiatry can help you connect with your fellow psychiatrists about complex mental health issues in the workplace.
The medical community must examine how and what we can do to welcome and serve the black and brown communities that may view us as the authority they dare not call.
Issues of well-being, especially during a disaster or pandemic, are not going to disappear. Dr Cross Hansel talks suicide prevention week and how to get patients back to their pre-pandemic mental health state.
Contesters of STAR*D discuss the impact and relevance of the study's remission rates.
Learn more about best practices when treating comorbid trauma and psychosis.
How can we prevent retraumatization of vulnerable individuals and enable them to seek redress?
Mental health leads with 36% of all outpatient visits and 39% of all telehealth services. What effect does this have on psychiatric practice?
It’s time to address adult ADHD.
What does existing research say about the connection between substance use disorders and eating disorders?
Are investors harming mental health care?
Larry Miller, MD, CEO of Apnimed, discusses the ins and outs of sleep apnea.
Panelists discuss the need for individualized narcolepsy management using complementary therapies like pitolisant, solriamfetol, and lower-sodium oxybate; emphasize persistence in overcoming insurance barriers through detailed documentation; and highlight practical adherence strategies alongside patient education and psychosocial support—including resources like Project Sleep and cognitive behavioral therapy—to optimize outcomes.
Trauma-related psychiatric disorders such as PTSD and grief often go undetected and untreated in older adults. Here's how to help.
New research links reduced synaptic density,early psychosis, and cannabis use, offering insights into negative symptoms and potential interventions.
The FDA Meeting of the Psychopharmacologic Drugs Advisory Committee evaluating the New Drug Application for MDMA is happening now. How do clinicians feel about this potential treatment for PTSD?
Brain Capital: a fresh approach to technologies and investing.
What are ghosts and ghouls compared to the looming threat of the declining global biological state?
What is the clinician’s role in reversing stigma for better outcomes?
To expertly utilize polypharmacy, it is imperative that clinicians stay abreast of new literature, check for drug-drug interactions, and be aware of emerging trends in drug use.
How important is it to understand a person’s ethnicity and cultural norms when developing a treatment plan?
Explore the relationship between cannabis use and psychosis.
Bipolar I disorder (BD-I) can be difficult to diagnose and treat due to overlapping symptoms and stigma. What can clinicians utilize to help manage BD-I for better long-term outcomes?
Financial success requires planning and thoughtfulness. What do female physicians wish they would have done differently or better?
This show is an example of how performances can be used to improve public mental health through inclusive and authentic positive representation, and inspiring hope.
Panelists discuss how a patient named Kerstin was diagnosed with attention-deficity/hyperactivity disorder (ADHD) later in life during college when she struggled with organization and scheduling beyond her known dyslexia, leading to successful treatment with various stimulant medications including participation in clinical trials.
Experts discuss that while anyone can experience perinatal mood and anxiety disorders, individuals with personal or family mental health histories, recent trauma, or medication changes are at higher risk, and emphasize the critical importance of informed, individualized medication management during pregnancy and lactation to balance risks, prevent undertreatment, and ensure the well-being of both parent and child.
If you missed this session, check out the highlights here!